Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DICLOFENAC\METAXALONE: 12 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
12
Total FAERS Reports
0
Deaths Reported
9
Hospitalizations
12
As Primary/Secondary Suspect
3
Life-Threatening
6
Disabilities

Active Ingredient: DICLOFENAC POTASSIUM\METAXALONE ·

First Report: 20210101 · Latest Report: 20210101

What Are the Most Common DICLOFENAC\METAXALONE Side Effects?

#1 Most Reported
Cardiac disorder
7 reports (58.3%)
#2 Most Reported
Wrong technique in product usage process
6 reports (50.0%)
#3 Most Reported
Weight increased
6 reports (50.0%)

All DICLOFENAC\METAXALONE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Cardiac disorder 7 58.3% 0 6
Abdominal distension 6 50.0% 0 6
Abdominal pain 6 50.0% 0 6
Abdominal pain lower 6 50.0% 0 6
Abdominal pain upper 6 50.0% 0 6
Abnormal faeces 6 50.0% 0 6
Asthenia 6 50.0% 0 6
Back pain 6 50.0% 0 6
Blood creatinine increased 6 50.0% 0 6
Chest pain 6 50.0% 0 6
Constipation 6 50.0% 0 6
Decreased appetite 6 50.0% 0 6
Diarrhoea 6 50.0% 0 6
Drug ineffective 6 50.0% 0 6
Fatigue 6 50.0% 0 6
Flushing 6 50.0% 0 6
Frequent bowel movements 6 50.0% 0 6
Gastric ulcer 6 50.0% 0 6
Gastrointestinal disorder 6 50.0% 0 6
Genitourinary tract neoplasm 6 50.0% 0 6

Who Reports DICLOFENAC\METAXALONE Side Effects? Age & Gender Data

Gender: 84.6% female, 15.4% male. Average age: 46.4 years. Most reports from: CA. View detailed demographics →

Is DICLOFENAC\METAXALONE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2021 2 0 2

View full timeline →

What Is DICLOFENAC\METAXALONE Used For?

IndicationReports
Pain in extremity 6
Product used for unknown indication 6

Official FDA Label for DICLOFENAC\METAXALONE

Official prescribing information from the FDA-approved drug label.